Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M\u20ac as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and investor relations as Chairman of the Board.<\/span>
<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"https:\/\/youtu.be\/Od1dhu8o228 Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M\u20ac as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and…<\/p>\n","protected":false},"author":1,"featured_media":1240,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[12,15],"tags":[],"aioseo_notices":[],"yoast_head":"\n
Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board - TreeFrog Therapeutics I iPS-derived cell therapies<\/title>\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n